Buspirone Effect on Breathlessness and Exercise Performance in Patients with Chronic Obstructive Pulmonary Disease
The DOI matches its Crossref record.
Abstract
Buspirone is an anxiolytic agent that appears to have no sedative effects. The aim of this study was to assess the effects of buspirone on breathlessness and exercise tolerance in patients with chronic airway obstruction. Sixteen patients, age 56.9 +/- 17.0; forced expiratory volume in 1 s (FEV1) 1.15 +/- 0.42 l; FEV1/forced vital capacity (FVC) 50.7 +/- 15.0%; PaCO2 42.2 +/- 5.5 mm Hg; and PaO2 57.6 +/- 10 mm Hg, underwent a 6-min walking test, an incremental cycle ergometer test, an incremental treadmill walking test with self-assessment of dyspnea on Borg's scale during exercise and an assessment of respiratory drive (P 0.1), timing [inspiration time (TI)/total breathing time (Ttot)], PaO2, PaCO2, FVC, FEV1, following oral administration for 14 days of placebo or buspirone (20 mg daily) in a double-blind, cross-over randomized way. We also used the symptom check list-90-R for the assessment of subjective complaints and symptomatic behavior. A significant improvement in anxiety, depression and obsessive symptoms and complaints was noted after buspirone treatment. The P 0.1, TI/Ttot, arterial blood gases and respiratory mechanics did not change after drug treatment. There was an improvement in exercise tolerance and in the sensation of dyspnea during the buspirone period. Thus, as given in this study, oral buspirone has therapeutic potential in the treatment of dyspnea in patients with chronic lung disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
McKenzie, D. K., & Frith, P. A. (2003) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05213.x · Cited by 369
Simon, S. T., Higginson, I. J., Booth, S., Harding, R., Weingärtner, V., & Bausewein, C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007354.pub3 · Cited by 358
Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review
Mikkelsen, R. L., Middelboe, T., Pisinger, C., & Stage, K. B. (2004) · Nordic Journal of Psychiatry · doi:10.1080/08039480310000824 · Cited by 345
“One study has proved the effect on anxiety and dyspnea in these patients (32), a result that could not be replicated in the study by Sing et al.”
ResultAnxiety and chronic obstructive pulmonary disease: prevalence, impact and treatment
Brenes, G. A. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000097339.75789.81 · Cited by 339
Anxiety and depression in end-stage COPD
Hill, K., Geist, R., Goldstein, R. S., & Lacasse, Y. (2008) · European Respiratory Journal · doi:10.1183/09031936.00125707 · Cited by 269
Metadata
- Authors
- Argyropoulou, P., Patakas, D., Koukou, A., Vasiliadis, P., & Georgopoulos, D.
- Venue
- Respiration
- Publisher
- S. Karger AG
- Published
- 1993
- Volume
- 60
- Issue
- 4
- Pages
- 216-220
- ISSN
- 0025-7931 (ISSN-L)
- 1423-0356
- OpenAlex
- W2056936235
- Cited by
- 106
- References
- 0
- FWCI
- 7.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Buspirone Effect on Breathlessness and Exercise Performance in Patients with Chronic Obstructive Pulmonary Disease. https://app.cochat.ai/papers/10.1159/000196202
- The paper
- Argyropoulou, P., Patakas, D., Koukou, A., Vasiliadis, P., & Georgopoulos, D. (1993). Buspirone Effect on Breathlessness and Exercise Performance in Patients with Chronic Obstructive Pulmonary Disease. Respiration. https://doi.org/10.1159/000196202
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.